Quest Partners LLC Acadia Pharmaceuticals Inc Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 9,208 shares of ACAD stock, worth $208,377. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,208
Previous 13,511
31.85%
Holding current value
$208,377
Previous $248 Million
38.31%
% of portfolio
0.02%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding ACAD
# of Institutions
353Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$970 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$344 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$273 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$193 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$158 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.66B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...